• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A novel prognostic signature in osteosarcoma characterised from the perspective of unfolded protein response.

作者信息

Shi Chengcheng, Zhao Faming, Zhang Tingting, Xu Denghui, Hao Zhuangyu, Cui Fengzhen, Shi Ji-Hua, Jin Yang, Li Ningning, Yang Caihong, Zhang Yi, Sheng Xia

机构信息

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Key Laboratory of Environmental Health, Ministry of Education & Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Clin Transl Med. 2022 Mar;12(3):e750. doi: 10.1002/ctm2.750.

DOI:10.1002/ctm2.750
PMID:35343090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8958346/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/11dd7b246fb2/CTM2-12-e750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/21738ab770d2/CTM2-12-e750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/fc65d34f9b6b/CTM2-12-e750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/ff72c94d0b2b/CTM2-12-e750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/11dd7b246fb2/CTM2-12-e750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/21738ab770d2/CTM2-12-e750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/fc65d34f9b6b/CTM2-12-e750-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/ff72c94d0b2b/CTM2-12-e750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c08/8958346/11dd7b246fb2/CTM2-12-e750-g002.jpg

相似文献

1
A novel prognostic signature in osteosarcoma characterised from the perspective of unfolded protein response.一种从未折叠蛋白反应角度表征的骨肉瘤新型预后标志物。
Clin Transl Med. 2022 Mar;12(3):e750. doi: 10.1002/ctm2.750.
2
Low-expression of lncRNA FER1L4 might be a prognostic marker in osteosarcoma.lncRNA FER1L4 低表达可能是骨肉瘤的预后标志物。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2310-2314. doi: 10.26355/eurrev_201804_14820.
3
Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.循环miR-25-3p作为骨肉瘤新型诊断和预后生物标志物的临床意义
Oncotarget. 2017 May 16;8(20):33375-33392. doi: 10.18632/oncotarget.16498.
4
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.用于骨肉瘤检测、治疗监测和预后的血浆微小RNA特征的跨物种鉴定
Cancer Med. 2015 Jul;4(7):977-88. doi: 10.1002/cam4.438. Epub 2015 Mar 17.
5
MIR-10b IS inversely correlated with higher tumor grade in osteosarcoma.在骨肉瘤中，MIR - 10b与较高的肿瘤分级呈负相关。
Clin Chim Acta. 2019 Mar;490:164-166. doi: 10.1016/j.cca.2017.11.030. Epub 2017 Nov 24.
6
Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma.分手并不难做到：骨肉瘤中无细胞游离 DNA 片段的分离。
Clin Cancer Res. 2023 Jun 1;29(11):2017-2019. doi: 10.1158/1078-0432.CCR-23-0390.
7
Epigenetic changes in osteosarcoma.骨肉瘤中的表观遗传变化。
Bull Cancer. 2011 Jul;98(7):E62-8. doi: 10.1684/bdc.2011.1400.
8
Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.循环miR-148a是骨肉瘤患者重要的诊断和预后生物标志物。
Tumour Biol. 2014 Dec;35(12):12467-72. doi: 10.1007/s13277-014-2565-x. Epub 2014 Sep 4.
9
miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.miR-421是骨肉瘤患者的一种诊断和预后标志物。
Tumour Biol. 2016 Jul;37(7):9001-7. doi: 10.1007/s13277-015-4578-5. Epub 2016 Jan 13.
10
The progress of molecular diagnostics of osteosarcoma.骨肉瘤分子诊断的研究进展。
Front Biosci (Landmark Ed). 2016 Jan 1;21(1):20-30. doi: 10.2741/4373.

引用本文的文献

1
The role of the unfolded protein response pathway in bone homeostasis and potential therapeutic target in cancer-associated bone disease.未折叠蛋白反应途径在骨稳态中的作用及在癌症相关骨病中的潜在治疗靶点。
Bone Res. 2025 Aug 28;13(1):76. doi: 10.1038/s41413-025-00457-6.
2
Identification of a novel unfolded protein response related signature for predicting the prognosis of acute myeloid leukemia.鉴定一种用于预测急性髓系白血病预后的新型未折叠蛋白反应相关特征。
Sci Rep. 2025 Feb 25;15(1):6705. doi: 10.1038/s41598-025-91524-9.
3
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis.

本文引用的文献

1
Endoplasmic reticulum stress signals in the tumour and its microenvironment.肿瘤及其微环境中的内质网应激信号。
Nat Rev Cancer. 2021 Feb;21(2):71-88. doi: 10.1038/s41568-020-00312-2. Epub 2020 Nov 19.
2
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?MYC 与癌症中的未折叠蛋白反应：协同犯罪的合成致死伙伴？
EMBO Mol Med. 2020 May 8;12(5):e11845. doi: 10.15252/emmm.201911845. Epub 2020 Apr 20.
3
Deconvoluting Stress-Responsive Proteostasis Signaling Pathways for Pharmacologic Activation Using Targeted RNA Sequencing.
单细胞和 bulk 转录组学的综合分析揭示了与骨肉瘤预后相关的细胞亚型和分子特征。
BMC Cancer. 2025 Feb 17;25(1):280. doi: 10.1186/s12885-025-13714-y.
4
Endoplasmic reticulum stress in diseases.疾病中的内质网应激
MedComm (2020). 2024 Aug 26;5(9):e701. doi: 10.1002/mco2.701. eCollection 2024 Sep.
5
Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.靶向IRE1α-XBP1s轴会使具有激活型Wnt信号的肝细胞癌产生选择性易损性。
Oncogene. 2024 Apr;43(17):1233-1248. doi: 10.1038/s41388-024-02988-4. Epub 2024 Feb 28.
6
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.利用人工智能衍生的预后指数，鉴定鲨烯环氧酶为高危骨肉瘤的代谢脆弱性。
Clin Transl Med. 2024 Feb;14(2):e1586. doi: 10.1002/ctm2.1586.
7
A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer.基于内质网应激相关基因的风险特征预测胰腺癌的预后和免疫情况。
Front Mol Biosci. 2023 Nov 29;10:1298077. doi: 10.3389/fmolb.2023.1298077. eCollection 2023.
8
Investigation of the activity of a novel tropolone in osteosarcoma.一种新型托酚酮在骨肉瘤中的活性研究。
Drug Dev Res. 2024 Feb;85(1):e22129. doi: 10.1002/ddr.22129. Epub 2023 Nov 14.
9
How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System.未折叠蛋白反应如何成为肿瘤的福音和免疫系统的祸根。
Immunohorizons. 2023 Apr 1;7(4):256-264. doi: 10.4049/immunohorizons.2200064.
10
Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.免疫原性细胞死亡的分子特征表明骨肉瘤的预后和肿瘤微环境浸润。
Front Immunol. 2022 Dec 9;13:1071636. doi: 10.3389/fimmu.2022.1071636. eCollection 2022.
利用靶向 RNA 测序技术对药物激活的应激响应蛋白稳态信号通路进行去卷积分析。
ACS Chem Biol. 2019 Apr 19;14(4):784-795. doi: 10.1021/acschembio.9b00134. Epub 2019 Mar 13.
4
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.IRE1α-XBP1s 通路通过激活 c-MYC 信号促进前列腺癌。
Nat Commun. 2019 Jan 24;10(1):323. doi: 10.1038/s41467-018-08152-3.
5
Osteosarcoma: a comprehensive review.骨肉瘤：一篇综述
SICOT J. 2018;4:12. doi: 10.1051/sicotj/2017028. Epub 2018 Apr 9.
6
Endoplasmic Reticulum Stress and the Hallmarks of Cancer.内质网应激与癌症特征
Trends Cancer. 2016 May;2(5):252-262. doi: 10.1016/j.trecan.2016.03.007. Epub 2016 Apr 23.
7
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation.小分子蛋白质稳态调节剂，可重新编程内质网以减少细胞外蛋白质聚集。
Elife. 2016 Jul 20;5:e15550. doi: 10.7554/eLife.15550.
8
Divergent androgen regulation of unfolded protein response pathways drives prostate cancer.不同的雄激素对未折叠蛋白反应途径的调节驱动前列腺癌。
EMBO Mol Med. 2015 Jun;7(6):788-801. doi: 10.15252/emmm.201404509.
9
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.ConsensusClusterPlus：一种具有置信度评估和项目跟踪功能的分类发现工具。
Bioinformatics. 2010 Jun 15;26(12):1572-3. doi: 10.1093/bioinformatics/btq170. Epub 2010 Apr 28.
10
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.乳腺癌中的基因表达谱分析：理解组织学分级的分子基础以改善预后。
J Natl Cancer Inst. 2006 Feb 15;98(4):262-72. doi: 10.1093/jnci/djj052.